JP2024505517A5 - - Google Patents
Info
- Publication number
- JP2024505517A5 JP2024505517A5 JP2023545783A JP2023545783A JP2024505517A5 JP 2024505517 A5 JP2024505517 A5 JP 2024505517A5 JP 2023545783 A JP2023545783 A JP 2023545783A JP 2023545783 A JP2023545783 A JP 2023545783A JP 2024505517 A5 JP2024505517 A5 JP 2024505517A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- formulation
- formulation according
- pilocarpine
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163142889P | 2021-01-28 | 2021-01-28 | |
| US63/142,889 | 2021-01-28 | ||
| PCT/US2022/014317 WO2022165178A1 (en) | 2021-01-28 | 2022-01-28 | Formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024505517A JP2024505517A (ja) | 2024-02-06 |
| JP2024505517A5 true JP2024505517A5 (cg-RX-API-DMAC7.html) | 2025-01-16 |
Family
ID=82494246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023545783A Pending JP2024505517A (ja) | 2021-01-28 | 2022-01-28 | 製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US11872213B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4284362A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024505517A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022212108A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3210064A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022165178A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220160668A1 (en) | 2020-11-23 | 2022-05-26 | Sight Sciences, Inc. | Formulations and methods for treating conditions of the eye |
| US11872213B2 (en) | 2021-01-28 | 2024-01-16 | Glaukos Corporation | Formulations |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
| ES2752008T3 (es) * | 2009-10-30 | 2020-04-02 | Intratus Inc | Métodos y composiciones para la liberación sostenida de fármacos |
| US9421199B2 (en) * | 2014-06-24 | 2016-08-23 | Sydnexis, Inc. | Ophthalmic composition |
| US11052094B2 (en) * | 2015-05-29 | 2021-07-06 | Sydnexis, Inc. | D2O stabilized pharmaceutical formulations |
| US20190262290A1 (en) * | 2016-10-12 | 2019-08-29 | Ps Therapies Ltd | Drug vehicle compositions and methods of use thereof |
| CN110996904A (zh) * | 2017-05-19 | 2020-04-10 | 奥古根有限公司 | 眼用组合物及使用方法 |
| JP6946575B2 (ja) * | 2018-04-24 | 2021-10-06 | アラーガン、インコーポレイテッドAllergan,Incorporated | 眼の状態の治療のためのピロカルピン塩酸塩の使用 |
| US11872213B2 (en) | 2021-01-28 | 2024-01-16 | Glaukos Corporation | Formulations |
| WO2024026365A1 (en) * | 2022-07-26 | 2024-02-01 | Glaukos Corporation | Ophthalmic topical cream formulations and uses thereof |
-
2022
- 2022-01-28 US US17/587,510 patent/US11872213B2/en active Active
- 2022-01-28 JP JP2023545783A patent/JP2024505517A/ja active Pending
- 2022-01-28 WO PCT/US2022/014317 patent/WO2022165178A1/en not_active Ceased
- 2022-01-28 AU AU2022212108A patent/AU2022212108A1/en active Pending
- 2022-01-28 CA CA3210064A patent/CA3210064A1/en active Pending
- 2022-01-28 EP EP22746694.3A patent/EP4284362A4/en active Pending
-
2023
- 2023-12-05 US US18/529,306 patent/US12533344B2/en active Active
-
2025
- 2025-12-30 US US19/436,767 patent/US20260124179A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7224390B2 (ja) | アトロピン含有水性組成物 | |
| CN102046149B (zh) | 稳定的眼药制剂 | |
| BRPI0607447B1 (pt) | Composição oftálmica de bimatoprosta aprimorada | |
| TW201204390A (en) | Novel ophthalmic compositions | |
| JP2002332248A (ja) | Gリッチなアルギン酸含有組成物 | |
| JP2014515383A (ja) | PGF2α類似体を含む眼科用製剤 | |
| JP3974431B2 (ja) | アルギン酸含有組成物 | |
| KR102638866B1 (ko) | 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법 | |
| JPWO2001087304A1 (ja) | 点眼剤 | |
| US20220233506A1 (en) | Formulations | |
| CA2851492A1 (en) | Ophthalmic gel compositions | |
| JP2002114711A (ja) | 外用剤組成物 | |
| CN110022856B (zh) | 用于降低眼压的眼用组合物 | |
| TW200927169A (en) | Complement Clq inhibitors for the prevention and treatment of glaucoma | |
| JP2005008596A (ja) | 眼科用組成物 | |
| CN103732224B (zh) | 用于眼睫毛生长的组合物 | |
| JPH01294633A (ja) | 点眼剤 | |
| JPH11130675A (ja) | クロマン誘導体含有点眼液 | |
| JP2006348055A (ja) | アルギン酸含有組成物 | |
| JP5999875B2 (ja) | ゲル状医薬組成物 | |
| US20230310429A1 (en) | Formulations for reducing hair loss and/or increasing hair regrowth | |
| HK40005358B (en) | Eye-drop composition for lowering intraocular pressure | |
| JP2010077160A (ja) | 眼科用組成物 | |
| HK40005358A (en) | Eye-drop composition for lowering intraocular pressure |